Foslevcromakalim (QLS-101) is a ATP-sensitive potassium channel opener. Foslevcromakalim is the proagent used for ocular potensive effect[1][2].
[1]. Pervan-Steel CL, et al. Ocular potensive Properties and Biochemical Profile of QLS-101, a Novel ATP-Sensitive Potassium (KATP) Channel Opening Prodrug. Invest Ophthalmol Vis Sci. 2022 Apr 1;63(4):26.
[2]. WHO Drug Information-World Health Organization (WHO).
















